Freshfields advised Merz Therapeutics on its $185 million acquisition of Acorda Therapeutics. Merz Therapeutics, a renowned entity in the neurotoxins sector, has entered into an agreement...
Merz Therapeutics’ $185m Acquisition of Acorda Therapeutics
PGGM’s Acquisition of RESA
Freshfields Bruckhaus Deringer has advised PGGM Infrastructure Fund on the deal. PGGM Infrastructure Fund acquired a 100% stake in RESA (Residencias de Estudiantes), the leading Spanish student...